NSI189, a small molecule with neurogenic properties, exerts behavioral, and neurostructural benefits in stroke rats
resM can say it "supports metabolism." It cannot say it "treats obesity" or "prevents diabetes." This is why you see careful language on the product page and why the product carries the standard disclaimer that it has not been evaluated by the FDA
Women who are pregnant, planning to conceive, or have specific conditions including active eating disorders or certain thyroid cancers may not be eligible
2021;610:121179 Elsevier B V
That means each treatment is backed by data and science, not guesswork
One of our providers will check in with you every 6 weeks to review your treatment plan, evaluate your progress, and adjust your dosage if needed